Trulieve Cannabis is trading 4.4% down at $11.29 after opening-day weakness on August 31, 2026.
- No clear company-specific announcement or fresh catalyst was identified in available coverage.
- Latest major developments were second-quarter results released August 7 and completion of the Delaware redomicile on August 11.
- Broader markets are also lower amid oil-supply concerns, geopolitical tensions, and renewed rate-hike fears, but the specific cause of this drop remains unclear.